PT  - JOURNAL ARTICLE
AU  - Daynes, E
AU  - Gerlis, C
AU  - Chaplin, E
AU  - Gardiner, N
AU  - Singh, S
TI  - Early experiences of rehabilitation for patients post-COVID to improve fatigue, breathlessness exercise capacity and cognition
AID  - 10.1101/2021.03.25.21254293
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.25.21254293
4099  - http://medrxiv.org/content/early/2021/03/28/2021.03.25.21254293.short
4100  - http://medrxiv.org/content/early/2021/03/28/2021.03.25.21254293.full
AB  - Patients with lasting symptoms of COVID-19 should be offered a comprehensive recovery programme. Patients that completed a six week, twice supervised adapted pulmonary rehabilitation programme demonstrated statistically significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition. Participants improved by 112m on the Incremental Shuttle Walking Test and 544 seconds on the Endurance Shuttle Walking Test. There were no serious adverse events recorded, and there were no dropouts related to symptom worsening. COVID-19 rehabilitation appears feasible and significantly improves clinical outcomes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN45695543Funding StatementThis study is supported by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the National Health Service Research Ethics Committee (reference 17/EM/0156)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.